EMILY DANVER: Open Payments
NPI 1851819049 · CLEARFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 29 payments from 17 companies in 2025. Trend: 2023 $300 · 2024 $651 · 2025 $708
Food & beverage: $608Education: $100
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $128 |
| Daiichi Sankyo Inc. | 2 | $125 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Eisai Inc. | 2 | $52 |
| Exelixis Inc. | 2 | $52 |
| Stemline Therapeutics Inc. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| GENZYME CORPORATION | 1 | $32 |
| Incyte Corporation | 1 | $25 |
| Genmab U.S., Inc. | 1 | $24 |
Products named: Enhertu, OPDIVO, KEYTRUDA, Lenvima, CABOMETYX, XTANDI, ELZONRIS, SARCLISA.
Industry payments across PA — which companies pay providers there.
